Literature DB >> 25739826

Inflammatory markers and mortality among US adults with obstructive lung function.

Earl S Ford1, Timothy J Cunningham, David M Mannino.   

Abstract

BACKGROUND AND
OBJECTIVE: Chronic obstructive pulmonary disease is characterized by an inflammatory state of uncertain significance. The objective of this study was to examine the association between elevated inflammatory marker count (white blood cell count, C-reactive protein and fibrinogen) on all-cause mortality in a national sample of US adults with obstructive lung function (OLF).
METHODS: Data for 1144 adults aged 40-79 years in the National Health and Nutrition Examination Survey III Linked Mortality Study were analysed. Participants entered the study from 1988 to 1994, and mortality surveillance was conducted through 2006. White blood cell count and fibrinogen were dichotomized at their medians, and C-reactive protein was divided into >3 and ≤3 g/L. The number of elevated inflammatory markers was summed to create a score of 0-3.
RESULTS: The age-adjusted distribution of the number of elevated inflammatory markers differed significantly among participants with normal lung function, mild OLF, and moderate or worse OLF. Of the three dichotomized markers, only fibrinogen was significantly associated with mortality among adults with any OLF (maximally adjusted hazard ratio 1.49; 95% confidence interval (CI): 1.17-1.91). The maximally adjusted hazard ratios for having 1, 2 or 3 elevated markers were 1.17 (95% CI: 0.71-1.94), 1.44 (95% CI: 0.89-2.32) and 2.08 (95% CI: 1.29-3.37), respectively (P=0.003).
CONCLUSIONS: An index of elevated inflammatory markers predicted all-cause mortality among adults with OLF.
© 2015 Asian Pacific Society of Respirology.

Entities:  

Keywords:  C-reactive protein; chronic obstructive pulmonary disease; fibrinogen; leukocytes; mortality

Mesh:

Substances:

Year:  2015        PMID: 25739826      PMCID: PMC4562426          DOI: 10.1111/resp.12499

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  34 in total

1.  Body mass index, diabetes, and C-reactive protein among U.S. adults.

Authors:  E S Ford
Journal:  Diabetes Care       Date:  1999-12       Impact factor: 19.112

2.  Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

Authors:  M A Albert; E Danielson; N Rifai; P M Ridker
Journal:  JAMA       Date:  2001-07-04       Impact factor: 56.272

3.  Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults.

Authors:  Earl S Ford
Journal:  Epidemiology       Date:  2002-09       Impact factor: 4.822

4.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

5.  Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels.

Authors:  I Jialal; D Stein; D Balis; S M Grundy; B Adams-Huet; S Devaraj
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

6.  Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis.

Authors:  B McConkey; P Davies; R A Crockson; A P Crockson; M Butler; T J Constable; R S Amos
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

7.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

8.  Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.

Authors:  Don D Sin; Paige Lacy; Ernest York; S F Paul Man
Journal:  Am J Respir Crit Care Med       Date:  2004-06-30       Impact factor: 21.405

Review 9.  Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.

Authors:  W Q Gan; S F P Man; A Senthilselvan; D D Sin
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

10.  Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.

Authors:  Peter Bogaty; James M Brophy; Martin Noel; Luce Boyer; Serge Simard; Fernand Bertrand; Gilles R Dagenais
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

View more
  6 in total

1.  Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals.

Authors:  Matthew R Gingo; Mehdi Nouraie; Cathy J Kessinger; Ruth M Greenblatt; Laurence Huang; Eric C Kleerup; Lawrence Kingsley; Deborah K McMahon; Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2018-02

2.  Fibrinogen as a potential biomarker for clinical phenotype in patients with chronic obstructive pulmonary disease.

Authors:  Tae Hoon Kim; Dong Kyu Oh; Yeon-Mok Oh; Sei Won Lee; Sang Do Lee; Jae Seung Lee
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 3.005

3.  Inflammatory status and lung function predict mortality in lung cancer screening participants.

Authors:  Ugo Pastorino; Daniele Morelli; Alfonso Marchianò; Stefano Sestini; Paola Suatoni; Francesca Taverna; Mattia Boeri; Gabriella Sozzi; Anna Cantarutti; Giovanni Corrao
Journal:  Eur J Cancer Prev       Date:  2018-07       Impact factor: 2.497

4.  Raised inflammatory markers as a predictor of one-year mortality: a cohort study in primary care in the UK using electronic health record data.

Authors:  Jessica Watson; Penny Whiting; Chris Salisbury; Jonathan Banks; Willie Hamilton
Journal:  BMJ Open       Date:  2020-10-15       Impact factor: 2.692

5.  Serum Human Epididymal Protein 4 is Associated with Depressive Symptoms in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Yan Shu; Wei Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-12-30

6.  Are elevated plasma fibrinogen associated with lung function? An 8-year follow-up of the ELSA study.

Authors:  Camila Thais Adam; Ione Jayce Ceola Schneider; Danielle Soares Rocha Vieira; Tauana Prestes Schmidt; Fernando Cesar Wehrmeister; Cesar de Oliveira
Journal:  PLoS One       Date:  2021-11-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.